Nppa

Govt, private sector need to work in tandem for increasing healthcare affordability: Experts

The government and private players need to work together in the healthcare sector to increase the affordability of medical services as rising cost impacts access to patients, experts said

Private Healthcare in India Part I: Artificially-inflated cost of medicine, consumables make non-govt hospitals inaccessible to most

Inflated medical bills, artificially increased costs of medical supplies and consumables have hampered access to private healthcare in India.

Private Healthcare in India Part III: Enforcing Clinical Establishment Act, capping drug costs can help regulate, reduce hospital bills

Clinical Establishment Act requires the Centre to set a range of rates for healthcare services. But neither the central nor any state govt has done so.

India rejects US request on price caps on medical devices as Centre aims to boost affordability of treatment

Price controls form part of PM Modi’s agenda to improve India’s dilapidated public health system and boost affordability of treatment.

Margins on drugs as high as 1,192% in four private hospitals: NPPA

Non-scheduled drugs and diagnostic services constituted major components of charges billed to patients in four private hospitals with margins as high as 1,192 percent, drug pricing regulator NPPA said on Tuesday

NPPA sets deadline to lower prices of syringes and needles; manufacturers volunteer, set trade margin at 75%

Syringe and needle manufacturers set trade margins at maximum 75 percent in an attempt to self-regulate prices; NPPA sets deadline to 26 January

Gurugram child dies of dengue: NPPA says Fortis overcharged patient's family by margin as high as 1700%

Fortis hospital at Gurgaon charged as high as 1,700 percent margin on consumables and medicines used for the treatment of a dengue patient who subsequently died of the illness, the National Pharmaceutical Pricing Authority (NPPA) said

Drug price regulator caps prices of 51 essential formulations used for cancer, heart, skin treatment

NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013

Centre fixes price ceiling of knee implants; NPPA notification brings huge relief for patients

The National Pharmaceutical Pricing Authority (NPPA) on Wednesday fixed the price for primary knee replacement of titanium alloy at Rs 38,740 while the price for revision knee replacement of any material was pegged at Rs 62,770.

Knee implants price capped; saving to patients Rs 1,500 cr, says govt

NPPA has capped the price of widely used Cromium Cobalt knee implants at Rs 54,720 from earlier Rs 1.58-Rs 2.5 lakh